ReviewDrug safety2026

Reassessing the Neoplasm Signal with Fezolinetant: Regulatory Inference, Mechanistic Plausibility, and the Case for Proactive Pharmacovigilance.

Glen Clack et al.PubMed ↗Publisher ↗

No numbers read from the abstract.